User profiles for M. Mulenga

Mwenge Mulenga

mwmulenga@mu.edu.zm
Verified email at mu.edu.zm
Cited by 184

Towards host-directed therapies for tuberculosis

…, E Macete, N Kapata, M Mulenga… - Nature reviews Drug …, 2015 - nature.com
… For the past 60 years, efforts to develop new treatments have focused on compounds
and regimens that target M. tuberculosis directly. Recently, however, attention has focused …

Natural Microbe-Mediated Refractoriness to Plasmodium Infection in Anopheles gambiae

…, SL Sandiford, JA Souza-Neto, M Mulenga… - Science, 2011 - science.org
Malaria parasite transmission depends on the successful transition of Plasmodium through
discrete developmental stages in the lumen of the mosquito midgut. Like the human intestinal …

Deep learning techniques for solar tracking systems: A systematic literature review, research challenges, and open research directions

M Phiri, M Mulenga, A Zimba, CI Eke - Solar Energy, 2023 - Elsevier
… As a result, this leads to insufficient technological usage as solar radiation flux does not
exceed 1 KW/m, even in some of the hottest regions on earth [72], [94]. See (Table 1). …

Biodiesel engine performance and emissions in low temperature combustion

M Zheng, MC Mulenga, GT Reader, M Wang, DSK Ting… - Fuel, 2008 - Elsevier
m e is the mass flow rate of the recycled gases, m a is the mass flow rate of the fresh air and
m … of air, MAF Total is the total mass air flow rate, m f is the fuel flow rate and [Air/Fuel] s is the …

Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems

…, J Logedi, A Nyandigisi, M Mulenga… - The Lancet infectious …, 2012 - thelancet.com
Artemisinin-resistant Plasmodium falciparum malaria has emerged in western Cambodia
and has been detected in western Thailand. The situation is ominously reminiscent of the …

[HTML][HTML] Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial

Q Bassat, M Mulenga, H Tinto, P Piola, S Borrmann… - PloS one, 2009 - journals.plos.org
Background Artemisinin combination therapies (ACTs) are currently the preferred option for
treating uncomplicated malaria. Dihydroartemisinin-piperaquine (DHA-PQP) is a promising …

[HTML][HTML] Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults—seven African …

…, F Wabwire-Mangen, G Kwesigabo, M Mulenga… - MMWR Morb Mortal …, 2014 - cdc.gov
Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to declines of
about 30% in the global annual number of human immunodeficiency (HIV)-related deaths …

Research Article (New England Journal of Medicine) Four artemisinin-based treatments in African pregnant women with malaria

…, U D'Alessandro, M Nambozi, M Mulenga… - Malawi Medical …, 2016 - ajol.info
Mulenga) assume responsibility for the overall content and integrity of the article. The full
names, degrees, and affiliations of the members of the writing group are listed in the Appendix. …

[PDF][PDF] Determination of sun protection factor (SPF) of some body creams and lotions marketed in Kinshasa by ultraviolet spectrophotometry

…, M Mulenga, PT Mpiana, K Bokolo, M Mumbwa… - Int. J. Adv. Res. Chem …, 2014 - Citeseer
The purpose of this study was to determine in vitro the sun protection factor (SPF) of somebody
creams and lotion sunscreens formulations marketed in Kinshasa containing physical and…

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia

…, AF Auld, S Agolory, JE Kaplan, M Mulenga… - Aids, 2015 - journals.lww.com
Objectives: To characterize antiretroviral therapy (ART) adherence across different programmes
and examine the relationship between individual and programme characteristics and …